68T-11435-98805

3 vaccinations 8 coded responses 37 check-ins 8 free-text entries 6 call cases

Sex: Male
Age at first dose: 41-45
ZIP prefix: 917 / CA
Registered: 2021-04-15

Relationship: Self
Race: Other
Ethnicity: Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-15
Registered in v-safe
2021-04-15
Dose 1 — Pfizer-BioNTech
2021-04-15
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-16
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activities

Adult check-in
2021-04-17
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activities

Adult check-in
2021-04-19
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches · Be unable to do your normal daily activities

Adult check-in
2021-04-20
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Muscle or body aches, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-04-21
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache · Be unable to do your normal daily activities

Adult check-in
2021-04-22
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-04-29
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-05-06
Dose 2 — Pfizer-BioNTech
2021-05-06
Health check-in — day 0, dose 2
Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-07
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2021-05-08
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activities

Adult check-in
2021-05-09
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activities

Adult check-in
2021-05-10
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Muscle or body aches · Be unable to do your normal daily activities

Adult check-in
2021-05-11
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Muscle or body aches · Be unable to do your normal daily activities

Adult check-in
2021-05-12
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Muscle or body aches · Be unable to do your normal daily activities

Adult check-in
2021-05-13
Health check-in — day 7, dose 2
Feeling: Fair · Headache

Adult check-in
2021-05-20
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-27
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-06-10
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-17
Survey response — day 42, dose 2
MedDRA: Hypersensitivity, Skin discolouration — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Allergic reaction. Left white spots on my hands.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-17
Report sent to call center — day 42, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-24
Call successful
Does not wish to fill out VAERS report
2021-08-06
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-11-04
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-05
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-01-05
Health check-in — day 0, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2022-01-06
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-01-07
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2022-01-08
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2022-01-09
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2022-01-10
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2022-01-11
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2022-01-12
Health check-in — day 7, dose 3
Feeling: Fair · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2022-01-19
Survey response — day 14, dose 3
MedDRA: Office visit, Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: Rash on hands and arms · Healthcare visit (other): Specialist on allergic reactions

MedDRA releases: 2024-11 · check-in free text available
2022-01-19
Report sent to call center — day 14, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2022-01-20
Call 1 — Could Not Reach Participant
2022-01-25
Call 2 — Could Not Reach Participant
2022-01-27
Survey response — day 21, dose 3
MedDRA: Rash, Scar — Feeling: Fair · Be unable to do your normal daily activities

Free text: Scars on my hands from rash

MedDRA releases: 2024-11 · check-in free text available
2022-02-02
Survey response — day 28, dose 3
MedDRA: Scar, Skin wrinkling, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional

Free text: Symptoms: Scars on hands getting bigger looks like skin is wrinkled. · Healthcare visit (other): Blood test and medicine like steroid cream and allergy medicine

MedDRA releases: 2024-11 · check-in free text available
2022-02-02
Report sent to call center — day 28, dose 3
Get care from a doctor or other healthcare professional

1 call case(s)
2022-02-03
Call successful
Does not wish to fill out VAERS report
2022-02-09
Survey response — day 35, dose 3
MedDRA: Rash — Feeling: Fair · Be unable to do your normal daily activities

Free text: Rash on hands and arms

MedDRA releases: 2024-11 · check-in free text available
2022-02-16
Survey response — day 42, dose 3
MedDRA: Office visit, Rash, Scar — Feeling: Fair · Get care from a doctor or other healthcare professional

Free text: Symptoms: Rash on hands continues, had various allergy test done including, blood, and skin. Not allergic to anything according to findings. Scarring continues. · Healthcare visit (other): Dr office

MedDRA releases: 2024-11 · check-in free text available
2022-02-16
Report sent to call center — day 42, dose 3
Get care from a doctor or other healthcare professional

1 call case(s)
2022-02-18
Call 1 — Requested Callback
2022-02-21
Call 2 — Left Voicemail
2022-02-21
Callback requested for
06:30PM ET
2022-04-06
Survey response — 3 months, dose 3
MedDRA: Rash, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: Rash on hands. · Healthcare visit (other): Prescription steroid cream and other medications. All allergy test have come back negative no allergies can be identified.

MedDRA releases: 2024-11 · check-in free text available
2022-04-06
Report sent to call center — 3 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2022-04-21
Call successful
Does not wish to fill out VAERS report
2022-07-08
Survey response — 6 months, dose 3
MedDRA: Rash — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Rashes on hands and arms

MedDRA releases: 2024-11 · check-in free text available
2022-07-08
Report sent to call center — 6 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-07-11
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-15	Pfizer-BioNTech
2	2021-05-06	Pfizer-BioNTech
3	2022-01-05	Pfizer-BioNTech	Flu

Call center

6 call center cases

5 successful · 1 unsuccessful

See the call center timeline

Free text

Release 9 — day 42, dose 2

2021-06-17

Symptoms: Allergic reaction. Left white spots on my hands.

Release 10 — day 14, dose 3

2022-01-19

Symptoms: Rash on hands and arms

Healthcare visit (other): Specialist on allergic reactions

Release 11 — day 21, dose 3

2022-01-27

Symptoms: Scars on my hands from rash

Release 11 — day 28, dose 3

2022-02-02

Symptoms: Scars on hands getting bigger looks like skin is wrinkled.

Healthcare visit (other): Blood test and medicine like steroid cream and allergy medicine

Release 11 — day 35, dose 3

2022-02-09

Symptoms: Rash on hands and arms

Release 11 — day 42, dose 3

2022-02-16

Symptoms: Rash on hands continues, had various allergy test done including, blood, and skin. Not allergic to anything according to findings. Scarring continues.

Healthcare visit (other): Dr office

Release 11 — 3 months, dose 3

2022-04-06

Symptoms: Rash on hands.

Healthcare visit (other): Prescription steroid cream and other medications. All allergy test have come back negative no allergies can be identified.

Release 12 — 6 months, dose 3

2022-07-08

Symptoms: Rashes on hands and arms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
HCVO	Unevaluable event	·	·	✓
SD	Hypersensitivity	✓	✓	✓
SD	Rash	·	·	✓
SD	Scar	·	·	✓
SD	Skin discolouration	·	·	✓
SD	Skin wrinkling	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release